|
In this new ACT ToxChats© episode, Dr. Jeffrey Foy, Vice President of Toxicology at Pepgen and Dr. Scott Henry, Vice President of Nonclinical Development at Ionis Pharmaceuticals are interviewed. Drs. Foy and Henry discuss the past, present, and future of oligonucleotides. Their focus is discussing the development and challenges that oligonucleotides face as a class of drugs.
ToxChats© episodes report on cutting-edge news in toxicological research from around the globe, and feature interviews with experts and reviews of current advances in toxicology. Tune in to learn about breakthroughs and regulatory developments in toxicological research, and more! We welcome any feedback or suggestions for future topics.
|